SEC Form EFFECT filed by Golden Path Acquisition Corporation
$GPCO
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | October 20, 2023 4:00 P.M. |
| Form: | F-3 | ||||||
| |||||||
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | October 20, 2023 4:00 P.M. |
| Form: | F-3 | ||||||
| |||||||
Save time and jump to the most important pieces.
6-K - MicroCloud Hologram Inc. (0001841209) (Filer)
6-K - MicroCloud Hologram Inc. (0001841209) (Filer)
6-K/A - MicroCloud Hologram Inc. (0001841209) (Filer)
3 - MicroCloud Hologram Inc. (0001841209) (Issuer)
3 - MicroCloud Hologram Inc. (0001841209) (Issuer)
3 - MicroCloud Hologram Inc. (0001841209) (Issuer)
NEW YORK, Sept. 16, 2022 /PRNewswire/ -- Golden Path Acquisition Corporation (the "Company" or "Golden Path") (NASDAQ:GPCO) today announced the closing of the previously announced business combination (the "Business Combination") with MC Hologram Inc. (the "MC") pursuant to which the Golden Path Merger Sub ("Golden Path Merger Sub"), a Cayman Islands exempted company incorporated for the purpose of effectuating the Business Combination merged with and into MC, with MC surviving the merger to become a wholly owned subsidiary of Golden Path. The Company is a publicly traded special purpose acquisition company or SPAC. As part of the transaction, the Company changed its name to "MicroCloud Holo
NEW YORK, June 22, 2022 /PRNewswire/ -- Golden Path Acquisition Corporation (the "Company" or "Golden Path") (NASDAQ:GPCO) (the "Company") today announced that the Company's sponsor, Greenland Asset Management Corporation (the "Sponsor"), has deposited into the Company's trust account (the "Trust Account") an aggregate of $191,667, representing $0.033 per public share of the Company, in order to extend the period of time the Company has to consummate a business combination by one month to July 24, 2022. The Sponsor plans to extend such period of time additional eight times to complete its initial business combination as necessary, each by an additional one months, up to March 24, 2023, by de
NEW YORK, Sept. 10, 2021 /PRNewswire/ -- Golden Path Acquisition Corporation (NASDAQ:GPCO) ("Golden Path"), a publicly traded special purpose acquisition company, and MC Hologram Inc. ("MC"), a Cayman Islands exempted company operating in China, announced today that they have entered into a definitive merger agreement. A newly created merger subsidiary of Golden Path will be merged with and into MC with MC being the surviving entity and becoming a wholly owned subsidiary of Golden Path. Upon closing of the transaction, Golden Path will change its name to MicroCloud Hologram Inc. The merger is structured as a stock for stock transaction and is intended to qualify as a tax-free reorganization.
Gainers Akero Therapeutics, Inc. (NASDAQ:AKRO) shares jumped 136.8% to settle at $29.05 on Tuesday after the company's Phase 2b HARMONY study met its primary endpoint for both the 50mg and 28mg EFX dose groups. Aditxt, Inc. (NASDAQ:ADTX) jumped 113.8% to close at $0.37. Comera Life Sciences Holdings, Inc. (NASDAQ:CMRA) surged 101% to close at $3.86 after a late Monday Form 4 filing showed multiple insider purchases of the stock. NeuroBo Pharmaceuticals, Inc. (NASDAQ:NRBO) climbed 79.3% to close at $29.90 on Tuesday as the stock started trading on a 1-for-30 reverse split basis. 89bio, Inc. (NASDAQ:ETNB) shares rose 40% to close at $7.00. Analysts reportedly said Akero's NASH data co
Gainers ShiftPixy, Inc. (NASDAQ:PIXY) shares surged 176.5% to close at $31.00 on Thursday after the company announced plans to spin-off ShiftPixy Labs and dividend its digital securities to shareholders. Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) gained 51% to settle at $27.03 after the FDA Advisory Committee voted that available evidence of effectiveness is sufficient to support approval of AMX0035 for the treatment of ALS. Citigroup and SVB Leerink raised their price targets. Rubius Therapeutics, Inc. (NASDAQ:RUBY) climbed 48.6% to close at $1.29 after declining 11% on Wednesday. Rubius Therapeutics, last month, posted a Q2 loss of $0.49 per share. Benitec Biopharma Inc. (NASDAQ:BNT
Gainers IMARA Inc. (NASDAQ:IMRA) jumped 74.8% to settle at $2.01 on Wednesday after the company announced it entered into an asset purchase agreement with Cardurion Pharmaceuticals to sell tovinontrine and other assets of its PDE9 program for $34.75 million upfront. Azure Power Global Limited (NYSE:AZRE) shares jumped 35.4% to close at $4.86. Azure Power Global recently announced the resignation of Harsh Shah as CEO. SelectQuote, Inc. (NYSE:SLQT) rose 28.8% to close at $1.43. Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) gained 27.7% to close at $36.40 amid post-IPO volatility. Spero Therapeutics, Inc. (NASDAQ:SPRO) shares jumped 26.6% to close at $1.43. Spero Therapeutics shar
SC 13G/A - MicroCloud Hologram Inc. (0001841209) (Subject)
SC 13G/A - MicroCloud Hologram Inc. (0001841209) (Subject)
SC 13G/A - MicroCloud Hologram Inc. (0001841209) (Subject)